CAS 42935-32-0

3,5-Diiodosalicylic acid lithium salt

CAS: 42935-32-0

3,5-Diiodosalicylic acid lithium salt is a potent inhibitor of kinases and has been studied for its potential use in cancer treatment. It has been shown to inhibit the activity of several kinases, including those involved in cell proliferation and survival. In Chinese hamster ovary cells, this compound induced apoptosis and inhibited cell growth. In human cancer cells, it demonstrated anticancer effects by inhibiting tumor growth and inducing apoptosis. Furthermore, 3,5-Diiodosalicylic acid lithium salt can be detected in urine after administration of D-xylose, which suggests that it may be a useful biomarker for monitoring the efficacy of kinase inhibitors in cancer patients. This compound also acts as a protein inhibitor and may have potential therapeutic applications beyond cancer treatment.

Formula: C₇H₃I₂LiO₃

Purity: Min. 95%

Molecular weight: 395.9 g/mol

Ref: 3D-SBA93532